Session 3 ‘Latest-generation cardiac devices: friends and foes'

29 June 2026

08h30 - 10h30

8h30-9h: Prevention and treatment of intracardiac devices infections (Christophe Leclercq, France)
9h-9h30: Transcatheter valve therapies (Anders Dahl, Denmark)
9h30-10h: Left Ventricular Assist Devices (Margaret Hannan, Ireland)
10h-10h30: Presentations selected from abstract submission

Candidemia in patients with cardiac implantable electric devices a population-based study - Andreas Berge, Stockholm, Sweden
Infective Endocarditis following transcatheter aortic and mitral valve replacement : Incidence, Predictors and Outcomes - Imane Idyahia, Paris, France
Oral Step-down of Antibiotic Therapy During Treatment of Left-sided Endocarditis due to Staphylococci, Streptococci and Enterococci: the RODEO non-inferiority randomized trial - Adrien Lemaignen, Tours, France